Raising Health

Adapting Biopharma to AI with Greg Meyers

Jorge Conde, Greg Meyers, Kris Tatiossian, and Olivia Webb

Posted June 1, 2023

Greg Meyers, EVP and Chief Digital and Technology Officer at Bristol Myers Squibb (or BMS), joins a16z Bio + Health general partner Jorge Conde.

Together, they talk about how AI could transform drug discovery and development at a large biopharma company—and how a company might have to adapt to harness AI; modalities they’re excited about; and Greg’s do’s and don’ts for startups looking to partner with a company like BMS.

Editors’ note: This episode was originally released on June 1, 2023, and rereleased on April 2, 2024.

More About This Podcast

Biology and the state of healthcare are undergoing radical shifts.
Raising Health delves into dialogues with scientists, technologists, founders, builders, leaders, and visionaries as they explore how AI, engineering, and technology elevate health to new heights and create a system of enduring health for all.

Learn More